Merck and Company
Dr. Tong-Ming Fu is a senior scientist at Merck Research Laboratories, and is leading the research lead for Merck CMV vaccine program. He obtained his medical degree at Peking University Health Science Center, formerly Beijing Medical University, in China, and his Ph.D. at Pennsylvania State University, Hershey Medical Center, in US. He joined Merck Research Laboratories after his academic trainings, and has been with Merck Vaccines Research for 20-years. He is active in many aspects of vaccine research, including vaccine target identifications, vaccine designs, immune assays, and animal model development, and his research supported development of Merck novel vaccine programs, including HIV-1 and influenza M2 peptide-conjugate vaccines. He also has research interests in DNA vaccine mechanisms, immune-enhancement by novel adjuvants and antibody-based immune modulations by PD- 1 blockade.
Infectious Diseases and Vaccines Research